Suppr超能文献

根治性前列腺切除术后局部复发前列腺癌早期诊断的先进影像学检查

Advanced imaging for the early diagnosis of local recurrence prostate cancer after radical prostatectomy.

作者信息

Panebianco Valeria, Barchetti Flavio, Musio Daniela, De Felice Francesca, Proietti Camilla, Indino Elena Lucia, Megna Valentina, Schillaci Orazio, Catalano Carlo, Tombolini Vincenzo

机构信息

Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, 00161 Rome, Italy.

Department of Diagnostic and Molecular Imaging, Interventional Radiology, Nuclear Medicine and Radiation Therapy, University Hospital "Tor Vergata", 00133 Rome, Italy.

出版信息

Biomed Res Int. 2014;2014:827265. doi: 10.1155/2014/827265. Epub 2014 Mar 13.

Abstract

Currently the diagnosis of local recurrence of prostate cancer (PCa) after radical prostatectomy (RT) is based on the onset of biochemical failure which is defined by two consecutive values of prostate-specific antigen (PSA) higher than 0.2 ng/mL. The aim of this paper was to review the current roles of advanced imaging in the detection of locoregional recurrence. A nonsystematic literature search using the Medline and Cochrane Library databases was performed up to November 2013. Bibliographies of retrieved and review articles were also examined. Only those articles reporting complete data with clinical relevance for the present review were selected. This review article is divided into two major parts: the first one considers the role of PET/CT in the restaging of PCa after RP; the second part is intended to provide the impact of multiparametric-MRI (mp-MRI) in the depiction of locoregional recurrence. Published data indicate an emerging role for mp-MRI in the depiction of locoregional recurrence, while the performance of PET/CT still remains unclear. Moreover Mp-MRI, thanks to functional techniques, allows to distinguish between residual glandular healthy tissue, scar/fibrotic tissue, granulation tissue, and tumour recurrence and it may also be able to assess the aggressiveness of nodule recurrence.

摘要

目前,前列腺癌根治术后局部复发的诊断基于生化失败的出现,生化失败由连续两次前列腺特异性抗原(PSA)值高于0.2 ng/mL定义。本文的目的是综述先进成像技术在检测局部区域复发中的当前作用。截至2013年11月,使用Medline和Cochrane图书馆数据库进行了非系统性文献检索。还查阅了检索到的文章和综述文章的参考文献。仅选择那些报告了对本综述具有临床相关性的完整数据的文章。这篇综述文章分为两个主要部分:第一部分探讨PET/CT在前列腺癌根治术后再分期中的作用;第二部分旨在阐述多参数MRI(mp-MRI)在描绘局部区域复发方面的影响。已发表的数据表明,mp-MRI在描绘局部区域复发方面正发挥着越来越重要的作用,而PET/CT的表现仍不明确。此外,由于具备功能技术,mp-MRI能够区分残留的健康腺组织、瘢痕/纤维化组织、肉芽组织和肿瘤复发,并且还可能能够评估结节复发的侵袭性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aac/3971570/24163812686f/BMRI2014-827265.001.jpg

相似文献

1
Advanced imaging for the early diagnosis of local recurrence prostate cancer after radical prostatectomy.
Biomed Res Int. 2014;2014:827265. doi: 10.1155/2014/827265. Epub 2014 Mar 13.
2
Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy.
Biomed Res Int. 2014;2014:316272. doi: 10.1155/2014/316272. Epub 2014 May 25.
7
The role of multiparametric mri in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy.
Actas Urol Esp (Engl Ed). 2022 Sep;46(7):397-406. doi: 10.1016/j.acuroe.2021.12.011. Epub 2022 Jun 28.
9
Prospective comparison of whole-body MRI and Ga-PSMA PET/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy.
Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1542-1550. doi: 10.1007/s00259-019-04308-5. Epub 2019 Mar 16.

引用本文的文献

2
Recurrent prostate cancer: combined role for MRI and PSMA-PET in Ga-PSMA-11 PET/MRI.
Eur Radiol. 2024 Jul;34(7):4789-4800. doi: 10.1007/s00330-023-10442-4. Epub 2023 Dec 1.
3
Management of Advanced and Metastatic Prostate Cancer: A Need for a Sub-Saharan Guideline.
J Oncol. 2019 Dec 5;2019:1785428. doi: 10.1155/2019/1785428. eCollection 2019.
4
Combining Diagnostic Imaging and Pathology for Improving Diagnosis and Prognosis of Cancer.
Contrast Media Mol Imaging. 2019 Jul 1;2019:9429761. doi: 10.1155/2019/9429761. eCollection 2019.
5
Discrimination of local recurrence after radical prostatectomy: value of diffusion-weighted magnetic resonance imaging.
Prostate Int. 2018 Mar;6(1):12-17. doi: 10.1016/j.prnil.2017.05.002. Epub 2017 May 25.
6
PET imaging of recurrent and metastatic prostate cancer with novel tracers.
Future Oncol. 2016 Nov;12(21):2463-2477. doi: 10.2217/fon-2016-0270. Epub 2016 Aug 16.
7
Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer.
Top Magn Reson Imaging. 2016 Jun;25(3):139-47. doi: 10.1097/RMR.0000000000000088.
8
Evaluating the Role of mpMRI in Prostate Cancer Assessment.
Expert Rev Med Devices. 2016;13(2):129-41. doi: 10.1586/17434440.2016.1134311. Epub 2016 Jan 28.
9
Spanish Society of Radiation Oncology clinical guidelines for stereotactic body radiation therapy in lymph node oligometastases.
Clin Transl Oncol. 2016 Apr;18(4):342-51. doi: 10.1007/s12094-015-1383-y. Epub 2015 Sep 2.

本文引用的文献

3
Dose-adapted salvage radiotherapy after radical prostatectomy based on an erMRI target definition model: toxicity analysis.
Acta Oncol. 2014 Jan;53(1):96-102. doi: 10.3109/0284186X.2013.837584. Epub 2013 Sep 13.
5
Boosting imaging defined dominant prostatic tumors: a systematic review.
Radiother Oncol. 2013 Jun;107(3):274-81. doi: 10.1016/j.radonc.2013.04.027. Epub 2013 Jun 20.
7
Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer.
Eur J Nucl Med Mol Imaging. 2013 Jul;40 Suppl 1:S28-35. doi: 10.1007/s00259-013-2404-0. Epub 2013 Apr 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验